SCHEMBL5822843

SCHEMBL5822843

COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1O.COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 13/20 0.73
▸ ERBB2 P04626 10/20 0.68
▸ RIPK2 O43353 2/20 0.68
▸ RET P07949 2/20 0.68
▸ EPHB2 P29323 2/20 0.68
▸ EPHB4 P54760 2/20 0.68
▸ EPHA4 P54764 2/20 0.68
▸ RIPK3 Q9Y572 2/20 0.68
▸ GAK O14976 1/20 0.68
▸ LYN P07948 1/20 0.68
▸ EPHA1 P21709 1/20 0.68
▸ ERBB3 P21860 1/20 0.68
▸ EPHA2 P29317 1/20 0.68
▸ EPHA5 P54756 1/20 0.68
▸ ADK P55263 1/20 0.68
▸ PTK6 Q13882 1/20 0.68
▸ MET P08581 1/20 0.61
▸ TEC P42680 1/20 0.61
▸ BTK Q06187 1/20 0.61
▸ KCNH2 Q12809 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29781334 0.96 EGFR (0.78) EGFRERBB2RIPK2RETEPHB2
SCHEMBL2456578 0.96 EGFR (0.78) EGFRERBB2RIPK2RETEPHB2
SCHEMBL202067 0.96 EGFR (0.78) EGFRERBB2RIPK2RETEPHB2
SCHEMBL13604778 0.94 EGFR (0.66) EGFRERBB2RIPK2RETEPHB2
SCHEMBL5821251 0.92 EGFR (0.72) EGFRERBB2RIPK2RETEPHB2
SCHEMBL6436466 0.92 EGFR (0.74) EGFRERBB2RIPK2RETEPHB2
SCHEMBL3132903 0.92 EGFR (0.74) EGFRERBB2RIPK2RETEPHB2
SCHEMBL3132783 0.92 EGFR (0.74) EGFRERBB2RIPK2RETEPHB2
SCHEMBL5210047 0.91 EGFR (0.85) EGFRERBB2RIPK2RETEPHB2
SCHEMBL3966911 0.89 EGFR (0.77) EGFRERBB2RIPK2RETEPHB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1670782-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2006-06-21 — — EP disclosed
WO-2005028470-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-03-31 — — WO disclosed
Send feedback